$CLVT

Clarivate Analytics beats top-line and bottom-line estimates; gives Q4 and updates FY26 ou

Clarivate Analytics reported Q3 Non-GAAP EPS of $0.21, exceeding estimates by $0.03. Revenue was $567.9M, down 8.9% year-over-year but beating expectations by $77.8M. Adjusted EBITDA decreased to $245.3M from $252.4M in Q3 2025. The company also provided Q4 and updated FY26 guidance.

Original reporting
Published Nov 3, 2026, 11:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CLVT
Bullish
high confidence
Mentioned
$CLVT
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CLVTBullishMed
01

Why it matters

The earnings beat may trigger a short‑term rally, but analysts will watch forward guidance and EBITDA trends.

02

Market read

Earnings beat is a fresh, material event for CLVT, offering a trading edge for short‑term positions.

03

What to watch

Adjusted EBITDA declined year‑over‑year, which could temper enthusiasm.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

Clarivate Analytics (CLVT) provides subscription‑based analytics and insights to research institutions and corporations.

Company-level read

Ticker impact

$CLVTBullishHigh confidence
Context

Clarivate Analytics reported Q3 Non‑GAAP EPS $0.21 beating estimates and revenue $567.9M beating forecasts.

Expected impact

likely upward pressure as investors price in the beat.

Evidence & confidence

Both EPS and revenue exceeded expectations, a classic catalyst for short‑term buying.

Market effects

Positive earnings may lift the information services sector.

U.S. market participants may view the beat as a sign of resilience in data‑analytics firms.

Limited to investors tracking U.S. listed analytics companies.

Counterpoint

If guidance is weak or future growth slows, the beat may be short‑lived.

Key entities

  • Clarivate Analytics

    U.S. listed provider of analytics and insights.

Related articles

$CLVTMed

Clarivate Plc Q3 2026 Earnings Call Summary

Clarivate reported Q3 2026 earnings, highlighting 1.8% organic ACV growth and 300 basis points of adjusted EBITDA margin expansion. The company completed the Life Sciences & Healthcare divestiture, focusing on higher-quality, recurring revenue. Management expects Q4 2026 organic revenue growth to exceed 2% and targets 10-15% free cash flow growth in 2027. One-time transaction costs of $30 million were incurred, and free cash flow guidance was adjusted to $320M-$340M.

$CLVTHighAI 8/10

Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation — Improved recurring organic revenue growth driven by portfolio transformation and AI-led innovation — — Updates 2026 financial outlook following the divestiture of Life Sciences & Healthcare

$CLVTMed

Why is Clarivate stock sliding today?

Clarivate (CLVT) stock fell 5.4% in pre-market trading after Q3 2026 results beat EPS estimates ($0.21 vs. $0.18) but missed revenue forecasts by 16.7% ($481.6M vs. $566.77M), down 9.2% YoY. Full-year revenue guidance ($1.96B-$1.98B) also fell short of consensus ($2.20B). The miss was exacerbated by portfolio disposals and cautious forward outlook.